摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(4-methoxyphenyl)-2H-azirine-2-carbaldehyde | 1433997-86-4

中文名称
——
中文别名
——
英文名称
3-(4-methoxyphenyl)-2H-azirine-2-carbaldehyde
英文别名
——
3-(4-methoxyphenyl)-2H-azirine-2-carbaldehyde化学式
CAS
1433997-86-4
化学式
C10H9NO2
mdl
——
分子量
175.187
InChiKey
KVNLEIGPKHCAEX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    38.7
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    2 H -1,3-恶嗪和1 H-吡咯-3(2 H)-one通过温度依赖性Rh(II)-类胡萝卜素介导的2 H -azirine-ring扩展的选择性合成
    摘要:
    2-羰基取代的2 H-叠氮基与2-氰基-2-重氮乙酸乙酯或2-重氮-3,3,3-三氟丙酸酯的Rh(II)催化反应可轻松获得2 H -1,3 -恶嗪和1 H-吡咯-3(2 H)-ones 。这些化合物可以使用温度作为唯一变化的参数,从相同的原料中选择性制备。两种杂环产物的共同前体2-azabuta-1,3-diene中间体在动力学控制下异构化为2 H -1,3-恶嗪,而1 H -pyrrol-3(2 H)-一个是在高温下反应的唯一产物。根据DFT计算,一个原子的恶嗪环收缩涉及开环成2-azabuta-1,3-二烯中间体,然后发生1,5-和1,2-质子性位移,导致连续形成亚氨基酰亚胺基和甲亚胺叶立德,然后进一步进行环化为吡咯衍生物。
    DOI:
    10.1016/j.tet.2014.03.101
  • 作为产物:
    描述:
    3-chloro-3-(4-methoxyphenyl)acrylaldehyde 在 sodium azide 作用下, 以 二甲基亚砜 为溶剂, 反应 0.25h, 以38%的产率得到3-(4-methoxyphenyl)-2H-azirine-2-carbaldehyde
    参考文献:
    名称:
    通过铑(II)类胡萝卜素向2 H -Azirine-2-carbaldimines的区域选择性加成合成1,2-二氢嘧啶-2-羧酸酯
    摘要:
    已经开发了一种有效的两步法“亚胺形成/叠氮基-类胡萝卜素偶联”,用于在Rh(II)催化下由叠氮基-2-甲醛,伯胺和重氮羰基化合物制备1,2-二氢嘧啶。1,2-二氢嘧啶的形成涉及将铑类胡萝卜素100%区域选择性加成到2 H -azirine-2-carbaldimine的环内氮原子上。根据DFT计算,反应通过将叠氮基内鎓盐的金属结合配合物解离为无金属的叠氮基吡啶,进行开环生成1,5-二氮杂六-1,3,5-三烯,然后进行1,6-环化。在C 2具有两个不同的吸电子取代基的1,2-二氢嘧啶位置可以通过“ N 1 -C 2键裂解/围绕NC单键/ 1,6-环化”旋转在C 2处的立体异构中心构型进行逆解。
    DOI:
    10.1021/acs.joc.7b02484
点击查看最新优质反应信息

文献信息

  • Synthesis of Pyrimido[1,2-<i>a</i>]indolediones and Pyrimidinediones via [4+2] Annulation of 2<i>H</i>-Azirine-2-carbaldehydes
    作者:Lesong Li、Zhenyu Shi、Congyang Li、Xiaoli Zhang、Yichi Zhang、Weiwu Ren
    DOI:10.1021/acs.joc.4c00654
    日期:——
    developed, providing straightforward synthetic protocols for constructing structurally intriguing pyrimido[1,2-a]indolediones and pyrimidinediones under mild conditions with excellent yields. This protocol can be used to synthesize the core skeleton of pharmaceutically important drugs and pyrimido[1,2-a]indoledione-containing natural products, making it potentially valuable for creating biologically
    已经开发出 NHC 催化的 2 H-氮丙啶-2-甲醛与酮亚胺和异氰酸酯的 [4+2] 成环反应,为在温和条件下构建结构有趣的嘧啶并[1,2- a ]吲哚二酮和嘧啶二酮提供了简单的合成方案,具有优异的合成性能。产量。该方案可用于合成药学上重要的药物和含嘧啶并[1,2- a ]吲哚二酮的天然产物的核心骨架,使其对于创建生物活性衍生物具有潜在价值。
  • Rh2(OAc)4-catalyzed reaction of α-diazocarbonyl compounds with 2-carbonyl-substituted 2H-azirines
    作者:Kirill V. Zavyalov、Mikail S. Novikov、Alexander F. Khlebnikov、Dmitry S. Yufit
    DOI:10.1016/j.tet.2013.04.022
    日期:2013.6
    The Rh-2(OAc)(4)-catalyzed reaction of 2H-azirine-2-carbaldehydes with dimethyl diazomalonate proceeds via azirinium ylide formation, isomerization to 2-azabuta-1,3-dienes followed by 1,6-pi-electrocyclization to give 2H-1,3-oxazines. According to DFT-calculations ring opening of azirinium ylides should occur stereoselectively to give 2-azadienes with the C=C bond exclusively in the Z configuration. Changing a formyl group for an acetyl group in the azirine leads to a lowering of stereoselectivity and the formation of azadienes with an E configuration of the C=C bond was observed. The reaction of 2-acy1-2-diazoacetates with 2H-azirine-2-carbaldehydes proceeds similarly, but the 2-acetyl-substituted 2H-1,3-oxazines formed are unstable under chromatographic purification and rearrange easily into pyrrole derivatives. (C) 2013 Elsevier Ltd. All rights reserved.
  • Synthesis of 1,2-Dihydropyrimidine-2-carboxylates via Regioselective Addition of Rhodium(II) Carbenoids to 2<i>H</i>-Azirine-2-carbaldimines
    作者:Mikhail S. Novikov、Nikolai V. Rostovskii、Alexander N. Koronatov、Kirill V. Zavyalov、Grigory V. Zubakin、Alexander F. Khlebnikov、Galina L. Starova
    DOI:10.1021/acs.joc.7b02484
    日期:2017.12.15
    An efficient two-step procedure “imine formation/azirine–carbenoid coupling” has been developed for the preparation of 1,2-dihydropyrimidines from azirine-2-carbaldehydes, primary amines, and diazo carbonyl compounds under Rh(II) catalysis. The formation of 1,2-dihydropyrimidines involves 100% regioselective addition of the rhodium carbenoid to endocyclic nitrogen atom of the 2H-azirine-2-carbaldimine
    已经开发了一种有效的两步法“亚胺形成/叠氮基-类胡萝卜素偶联”,用于在Rh(II)催化下由叠氮基-2-甲醛,伯胺和重氮羰基化合物制备1,2-二氢嘧啶。1,2-二氢嘧啶的形成涉及将铑类胡萝卜素100%区域选择性加成到2 H -azirine-2-carbaldimine的环内氮原子上。根据DFT计算,反应通过将叠氮基内鎓盐的金属结合配合物解离为无金属的叠氮基吡啶,进行开环生成1,5-二氮杂六-1,3,5-三烯,然后进行1,6-环化。在C 2具有两个不同的吸电子取代基的1,2-二氢嘧啶位置可以通过“ N 1 -C 2键裂解/围绕NC单键/ 1,6-环化”旋转在C 2处的立体异构中心构型进行逆解。
  • Selective syntheses of 2H-1,3-oxazines and 1H-pyrrol-3(2H)-ones via temperature-dependent Rh(II)-carbenoid-mediated 2H-azirine-ring expansion
    作者:Kirill V. Zavyalov、Mikail S. Novikov、Alexander F. Khlebnikov、Viktoriia V. Pakalnis
    DOI:10.1016/j.tet.2014.03.101
    日期:2014.5
    the reaction at elevated temperatures. According to DFT-calculations a one-atom oxazine ring contraction involving ring-opening to a 2-azabuta-1,3-diene intermediate, followed by a 1,5- and 1,2-prototropic shift leads to the consecutive formation of imidoylketene and azomethine ylide, which then further undergo cyclization to the pyrrole derivative.
    2-羰基取代的2 H-叠氮基与2-氰基-2-重氮乙酸乙酯或2-重氮-3,3,3-三氟丙酸酯的Rh(II)催化反应可轻松获得2 H -1,3 -恶嗪和1 H-吡咯-3(2 H)-ones 。这些化合物可以使用温度作为唯一变化的参数,从相同的原料中选择性制备。两种杂环产物的共同前体2-azabuta-1,3-diene中间体在动力学控制下异构化为2 H -1,3-恶嗪,而1 H -pyrrol-3(2 H)-一个是在高温下反应的唯一产物。根据DFT计算,一个原子的恶嗪环收缩涉及开环成2-azabuta-1,3-二烯中间体,然后发生1,5-和1,2-质子性位移,导致连续形成亚氨基酰亚胺基和甲亚胺叶立德,然后进一步进行环化为吡咯衍生物。
查看更多

同类化合物

[(2S)-3-苯基-2H-氮杂环丙烯-2-基]甲醇 3-苯基-2H-氮丙啶-2-甲醛 3-(4-硝基苯基)-2H-吖丙因 3-(4-甲基苯基)-2H-吖丙因-2-甲醛 2H-氮丙啶 2-甲基-3-苯基-2H-吖丙因-2-甲醛 1H-氮丙啶 1-(3-苯基-2H-氮杂环丙烯-2-基)乙酮 (3-苯基-2H-氮杂环丙烯-2-基)甲醇 2-benzyl-3-phenyl-2H-azirine phenyl 3-phenyl-2H-aziren-2-ylsulfide <(3'-phenyl-2'H-azirin-2'-yl)methyl>phosphonic acid diethyl ester 3-(4-(tert-butyl)phenyl)-2H-azirine 3-phenyl-2H-azirine-2-methanol 3-Methyl-2-(4-nitrophenyl)-2H-azirine 3-(4-bromophenyl)-2H-azirine-2-carboxaldehyde 4-methoxy-N-(3-phenyl-2H-azirin-2-ylmethylene)-aniline 3-(3-Methoxyphenyl)-2,2-dimethyl-2H-azirene 3-(o-chlorophenyl)-2,2-dimethyl-2H-azirine 2-(3-chlorophenyl)-3-methyl-2H-azirine-2-carbonitrile (E)-3-(3-Phenyl-2H-azirin-2-yl)-propenal 3-Methyl-2-phenylazirin (E)-2-(2-Butenyl)-2-methyl-3-phenyl-2H-azirin 2-methyl-2-(3-methyl-2-butenyl)-3-phenyl-2H-azirine methyl-2,phenyl-2,ethyl-3 aziridine 3-but-3-enyl-2-methyl-2-phenyl-2H-azirine 2,3-dimethyl-2-phenyl-2H-azirine 2,2-dimethyl-3-(4-t-butylphenyl)-2H-azirine 2-Methyl-2-methallyl-3-phenyl-2H-azirin methyl 2-(2-methoxy-6-methylphenyl)-2H-azirine-3-carboxylate 2-[3-(3-bromophenyl)-2H-azirin-2-yl]-5-(trifluoromethyl)pyridine ethyl 2-(2-methoxyphenyl)-2H-azirine-3-carboxylate 3-(4-fluorophenyl)-2-(2-(5-trifluoromethyl)pyridyl)-2H-azirine (E)-1-Phenyl-3-(3-phenyl-2H-azirin-2-yl)-propenone 2-bromo-3-phenyl-2-phenylsulfonylmethyl-2H-azirine 2-cyano-2H-azirene diethyl(3-phenyl-2-H-azirin-2-yl) phosphonate diethyl(-)-S-(3-phenyl-2-H-azirin-2-yl) phosphonate 2-methyl-3-phenyl-2-(2-phenylethyl)azirine (butene-3'yl)-2 methyl-2 phenyl-3 2H-azirine 2-methyl-2-(pent-4-en-1-yl)-3-phenyl-2H-azirine 2-(Dimethoxymethyl)-3-phenyl-2H-azirin 3-(4-methoxyphenyl)-2H-azirine-2-carbaldehyde methyl 2-(2,3,4-trimethoxy-6-methylphenyl)-2H-azirine-3-carboxylate 2-(2-bromophenyl)-3-methyl-2H-azirine 2-(2,4-dimethylphenyl)azirine 3-methyl-2-o-tolyl-2H-azirine-2-carbonitrile 2-azido-2-formyl-3-phenyl-2H-azirine 2,3-dimethyl-1H-azirine 2-(4-fluorophenyl)-3-methyl-2H-azirine-2-carbonitrile